LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,193
تعداد مقالات10,869
تعداد مشاهده مقاله73,332,764
تعداد دریافت فایل اصل مقاله14,919,919
Amoozgar, Hamid, Arabi, Hamid, Edraki, Mohammadreza, Naghshzan, Amir, Mehdizadegan, Nima, Mohammadi, Hamid, Nobakhti, Mohammadjavad, Keshavarz, Kambiz. (1404). Short and Mid-term Outcomes of Percutaneous Perimembranous Ventricular Septal Defect Closure Using Amplatzer Duct Occluders Type II in Children and Adolescents. سامانه مدیریت نشریات علمی, 50(6), 393-403. doi: 10.30476/ijms.2024.102819.3595
Hamid Amoozgar; Hamid Arabi; Mohammadreza Edraki; Amir Naghshzan; Nima Mehdizadegan; Hamid Mohammadi; Mohammadjavad Nobakhti; Kambiz Keshavarz. "Short and Mid-term Outcomes of Percutaneous Perimembranous Ventricular Septal Defect Closure Using Amplatzer Duct Occluders Type II in Children and Adolescents". سامانه مدیریت نشریات علمی, 50, 6, 1404, 393-403. doi: 10.30476/ijms.2024.102819.3595
Amoozgar, Hamid, Arabi, Hamid, Edraki, Mohammadreza, Naghshzan, Amir, Mehdizadegan, Nima, Mohammadi, Hamid, Nobakhti, Mohammadjavad, Keshavarz, Kambiz. (1404). 'Short and Mid-term Outcomes of Percutaneous Perimembranous Ventricular Septal Defect Closure Using Amplatzer Duct Occluders Type II in Children and Adolescents', سامانه مدیریت نشریات علمی, 50(6), pp. 393-403. doi: 10.30476/ijms.2024.102819.3595
Amoozgar, Hamid, Arabi, Hamid, Edraki, Mohammadreza, Naghshzan, Amir, Mehdizadegan, Nima, Mohammadi, Hamid, Nobakhti, Mohammadjavad, Keshavarz, Kambiz. Short and Mid-term Outcomes of Percutaneous Perimembranous Ventricular Septal Defect Closure Using Amplatzer Duct Occluders Type II in Children and Adolescents. سامانه مدیریت نشریات علمی, 1404; 50(6): 393-403. doi: 10.30476/ijms.2024.102819.3595

Short and Mid-term Outcomes of Percutaneous Perimembranous Ventricular Septal Defect Closure Using Amplatzer Duct Occluders Type II in Children and Adolescents

Iranian Journal of Medical Sciences
مقاله 4، دوره 50، شماره 6، شهریور 2025، صفحه 393-403    اصل مقاله (1.01 M)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2024.102819.3595
نویسندگان
Hamid Amoozgar1؛ Hamid Arabi1؛ Mohammadreza Edraki* 1؛ Amir Naghshzan1؛ Nima Mehdizadegan1؛ Hamid Mohammadi1؛ Mohammadjavad Nobakhti2؛ Kambiz Keshavarz3
1Department of Pediatrics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
2Department of Cardiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
3Department of Pediatrics, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
چکیده
Background: Percutaneous closure of perimembranous ventricular septal defects (pmVSD) with Amplatzer duct occluder type II (ADO II) is a novel method. The present study aimed to evaluate the short and mid-term outcomes of this method in children and adolescents. 
Methods: This retrospective study was conducted at Shiraz University of Medical Sciences from July 2019 to September 2023. It evaluated the outcomes of pmVSD closure using the ADO II. The effects on tricuspid regurgitation (TR), mitral regurgitation (MR), and aortic regurgitation (AR) were assessed, along with the presence of residual shunts and conduction disturbances. Data were analyzed using SPSS software (version 24.0). Fisher’s exact test and the Chi square test were employed for statistical analysis. P<0.05 was considered statistically significant.
Results: This study included 102 patients. 31 patients had a short-term follow-up with a median of 79 (71.02, 97.01) days, and 71 patients had a mid-term follow-up with a median of 900 (384.25, 1044.75) days. The severity of TR, MR, and AR dropped to lower levels in most patients during follow-ups (P=0.003, P=0.030, and P=0.033, respectively). There was no significant difference in the valvar regurgitation changes between patients weighing more or less than 10 Kg or between those with short and mid-term follow-ups (P>0.05). There were no hemolysis, clot, embolization, death, or third-degree atrioventricular blocks. However, 2 (2%) patients developed a small residual shunt.
Conclusion: Overall, ADO II appeared to be a safe transcatheter occlusion device for patients with pmVSD, and this method could reduce the severity of TR, MR, and AR with few complications.

تازه های تحقیق

Hamid Amoozgar (Google Scholar)

Mohammadreza Edraki (Google Scholar)

کلیدواژه‌ها
Heart septal defects؛ Septal occluder device؛ Cardiac catheterization
مراجع
  1. Zhao J, Li J, Wei X, Zhao B, Sun W. Tricuspid valve detachment in closure of congenital ventricular septal defect. Tex Heart Inst J. 2003;30:38-41. PubMed PMID: 12638669; PubMed Central PMCID: PMCPMC152833.
  2. Sarkislali K, Kalangos A. Late Tricuspid Regurgitation after Percutaneous Transcatheter Closure of Ventricular Septal Defect: an Educational Presentation. Braz J Cardiovasc Surg. 2021;36:253-6. doi: 10.21470/1678-9741-2020-0172. PubMed PMID: 33577256; PubMed Central PMCID: PMCPMC8163272.
  3. Said SM, Dearani JA, Burkhart HM, Connolly HM, Eidem B, Stensrud PE, et al. Management of tricuspid regurgitation in congenital heart disease: is survival better with valve repair? J Thorac Cardiovasc Surg. 2014;147:412-7. doi: 10.1016/j.jtcvs.2013.08.034. PubMed PMID: 24084288.
  4. Mertens L, Meyns B, Gewillig M. Device fracture and severe tricuspid regurgitation after percutaneous closure of perimembranous ventricular septal defect: a case report. Catheter Cardiovasc Interv. 2007;70:749-53. doi: 10.1002/ccd.21198. PubMed PMID: 17563097.
  5. Liu SP, Li L, Yao KC, Wang N, Wang JC. Investigation of membranous ventricular septal defect complicated with tricuspid regurgitation in ventricular septal defect occlusion. Exp Ther Med. 2013;5:865-9. doi: 10.3892/etm.2012.876. PubMed PMID: 23404058; PubMed Central PMCID: PMCPMC3570173.
  6. Topcuoglu MS, Atalay A, Gocen U, Guzel Y, Basturk Y, Demir F. An Unusual Complication of the Ventricular Septal Defect Closure by Device: Late Right Aortic Cusp Perforation. Heart Lung Circ. 2015;24:e118-21. doi: 10.1016/j.hlc.2014.11.010. PubMed PMID: 25937396.
  7. Tang C, Shao S, Zhou K, Hua Y, Luo C, Wang C. Complete Left Bundle-Branch Block After Transcatheter Closure of Perimembranous Ventricular Septal Defect Using Amplatzer Duct Occluder II. J Am Heart Assoc. 2022;11:e022651. doi: 10.1161/JAHA.121.022651. PubMed PMID: 35350872; PubMed Central PMCID: PMCPMC9075492.
  8. Cen H, Peng B, Li J, Chen S, Sun P. Efficacy and safety of the Amplatzer Duct Occluder II for ventricular septal defect closure: a meta-analysis. Kardiol Pol. 2021;79:401-9. doi: 10.33963/KP.15762. PubMed PMID: 33506659.
  9. Amoozgar H, Edraki MR, Naghshzan A, Mehdizadegan N, Mohammadi H, Ajami G, et al. Midterm follow up of transcatheter closure of coronary artery fistula with Nit-Occlud(R) patent ductus arteriosus coil. BMC Cardiovasc Disord. 2021;21:192. doi: 10.1186/s12872-021-01999-3. PubMed PMID: 33879042; PubMed Central PMCID: PMCPMC8056487.
  10. Jiang D, Zhang J, Fan Y, Han B, Zhao L, Yi Y, et al. The Efficacy and Medium to Long-Term Follow-Up of Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects via the Femoral Artery With Amplatzer Duct Occluder II in Children. Front Pediatr. 2021;9:571407. doi: 10.3389/fped.2021.571407. PubMed PMID: 34113582; PubMed Central PMCID: PMCPMC8185017.
  11. Sievert H, Franke J, Qureshi SA, Bertog S, Wilson N, Gafoor S, et al. Interventions in structural, Valvular and congenital heart disease. 2nd ed. London: CRC Press; 2015. doi: 10.1201/b17909.
  12. Amoogzar H, Shakiba AM, Derakhshan D, Ajami G, Cheriki S, Borzouee M, et al. Evaluation of left ventricular function by tissue Doppler and speckle-derived strain rate echocardiography after percutaneous ductus closure. Pediatr Cardiol. 2015;36:219-25. doi: 10.1007/s00246-014-0989-0. PubMed PMID: 25107547.
  13. Sugiyama H, Hoshiai M, Tan T, Nakazawa S. Functional maturity of tricuspid and mitral valves in school children evaluated by echocardiography. Heart. 2005;91:1479-80. doi: 10.1136/hrt.2004.057083. PubMed PMID: 16230453; PubMed Central PMCID: PMCPMC1769171.
  14. Eidem BW. Functional Evaluation of the Heart by Transesophageal Echocardiography. Transesophageal Echocardiography for Congenital Heart Disease. 2014:121-44. doi: 10.1007/978-1-84800-064-3_5.
  15. Amoozgar H, Soltani R, Edraki M, Mehdizadegan N, Mohammadi H, Ajami G, et al. Hemolysis and its outcome following percutaneous closure of cardiac defects among children and adolescents: a prospective study. Ital J Pediatr. 2019;45:128. doi: 10.1186/s13052-019-0728-5. PubMed PMID: 31627743; PubMed Central PMCID: PMCPMC6798493.
  16. Polat TB, Turkmen E. Transcatheter closure of ventricular septal defects using the Amplatzer Duct Occluder II device: a single-center experience. Postepy Kardiol Interwencyjnej. 2016;12:340-7. doi: 10.5114/aic.2016.63635. PubMed PMID: 27980548; PubMed Central PMCID: PMCPMC5133323.
  17. Narin N, Baykan A, Pamukcu O, Argun M, Ozyurt A, Mese T, et al. ADO II in Percutaneous VSD Closure in Pediatric Patients. J Interv Cardiol. 2015;28:479-84. doi: 10.1111/joic.12222. PubMed PMID: 26345701.
  18. Kanaan M, Ewert P, Berger F, Assa S, Schubert S. Follow-up of patients with interventional closure of ventricular septal defects with Amplatzer Duct Occluder II. Pediatr Cardiol. 2015;36:379-85. doi: 10.1007/s00246-014-1017-0. PubMed PMID: 25179462.
  19. Zhao LJ, Han B, Zhang JJ, Yi YC, Jiang DD, Lyu JL. Transcatheter closure of congenital perimembranous ventricular septal defect using the Amplatzer duct occluder 2. Cardiol Young. 2018;28:447-53. doi: 10.1017/S1047951117002396. PubMed PMID: 29233213.
  20. Haddad RN, Daou L, Saliba Z. Device Closure of Perimembranous Ventricular Septal Defect: Choosing Between Amplatzer Occluders. Front Pediatr. 2019;7:300. doi: 10.3389/fped.2019.00300. PubMed PMID: 31475122; PubMed Central PMCID: PMCPMC6707042.
  21. Xu XD, Liu SX, Bai Y, Zhang M, Zhao XX, Qin YW. Decreased tricuspid regurgitation following percutaneous closure of congenital perimembranous ventricular septal defect: immediate and 6-month echocardiographic assessment. Heart Vessels. 2015;30:611-7. doi: 10.1007/s00380-014-0531-6. PubMed PMID: 24946869.
  22. Yang J, Yang L, Yu S, Liu J, Zuo J, Chen W, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol. 2014;63:1159-68. doi: 10.1016/j.jacc.2014.01.008. PubMed PMID: 24509270.
  23. Kuwelker SM, Shetty DP, Dalvi B. Surgical repair of tricuspid valve leaflet tear following percutaneous closure of perimembranous ventricular septal defect using Amplatzer duct occluder I: Report of two cases. Ann Pediatr Cardiol. 2017;10:61-4. doi: 10.4103/0974-2069.197052. PubMed PMID: 28163430; PubMed Central PMCID: PMCPMC5241847.
  24. Rahmath MR, Numan M, Dilawar M. Medium to long-term echo follow-up after ventricular septal defect device closure. Asian Cardiovasc Thorac Ann. 2016;24:422-7. doi: 10.1177/0218492316645746. PubMed PMID: 27112358.
  25. Kulyabin YY, Soynov IA, Zubritskiy AV, Voitov AV, Nichay NR, Gorbatykh YN, et al. Does mitral valve repair matter in infants with ventricular septal defect combined with mitral regurgitation? Interact Cardiovasc Thorac Surg. 2018;26:106-11. doi: 10.1093/icvts/ivx231. PubMed PMID: 29049781.
  26. Cho HJ, Ma JS, Cho YK, Ahn BH, Na KJ, Jeong IS. Timing in resolution of left heart dilation according to the degree of mitral regurgitation in children with ventricular septal defect after surgical closure. J Pediatr (Rio J). 2014;90:71-7. doi: 10.1016/j.jped.2013.06.008. PubMed PMID: 24140379.
  27. Mahadin DR, Srivastava S, Parness IA, Nguyen K, Love BA, Walsh R, et al. Outcomes of mitral regurgitation associated with large ventricular septal defect and a normal mitral valve apparatus: does intact atrial septum have an impact? Pediatr Cardiol. 2011;32:1128-31. doi: 10.1007/s00246-011-9994-8. PubMed PMID: 21512787.
  28. Lin HC, Lin MT, Chen CA, Hsu JY, Lin SM, Wu MH, et al. Safety and efficacy of transcatheter closure of outlet-type ventricular septal defects in children and adults with Amplatzer Duct Occluder II. J Formos Med Assoc. 2021;120:180-8. doi: 10.1016/j.jfma.2020.04.015. PubMed PMID: 32402520.
  29. Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, et al. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv. 2006;68:620-8. doi: 10.1002/ccd.20659. PubMed PMID: 16969878.
  30. Ghosh S, Sridhar A, Sivaprakasam M. Complete heart block following transcatheter closure of perimembranous VSD using amplatzer duct occluder II. Catheter Cardiovasc Interv. 2018;92:921-4. doi: 10.1002/ccd.27177. PubMed PMID: 28707408.
آمار
تعداد مشاهده مقاله: 73
تعداد دریافت فایل اصل مقاله: 54


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب